Next generation sequencing technology: Advances and applications  by Buermans, H.P.J. & den Dunnen, J.T.
Biochimica et Biophysica Acta 1842 (2014) 1932–1941
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbad isReviewNext generation sequencing technology: Advances and applications☆H.P.J. Buermans 1, J.T. den Dunnen ⁎
Leiden Genome Technology Center, Leiden University Medical Center, Postbus 9600, 2300 RC Leiden, The Netherlands☆ This article is part of a Special Issue entitled: From Ge
⁎ Corresponding author: Tel.: + 31 715269400; fax: +
E-mail addresses: h.buermans@lumc.nl (H.P.J. Buerma
(J.T. den Dunnen).
1 Tel.: +31 715269400; fax: +31 71 5268285.
http://dx.doi.org/10.1016/j.bbadis.2014.06.015
0925-4439/© 2014 Elsevier B.V. All rights reserved.a b s t r a c ta r t i c l e i n f oArticle history:
Received 22 November 2013
Received in revised form 5 June 2014
Accepted 15 June 2014
Available online 1 July 2014
Keywords:
Next generation sequencing
Sequence by synthesis
Nanopore
Single molecule sequencing
Basic technology
ApplicationsImpressive progress has beenmade in the ﬁeld of Next Generation Sequencing (NGS). Through advancements in
the ﬁelds of molecular biology and technical engineering, parallelization of the sequencing reaction has pro-
foundly increased the total number of produced sequence reads per run. Current sequencing platforms allow
for a previously unprecedented view into complex mixtures of RNA and DNA samples. NGS is currently evolving
into a molecular microscope ﬁnding its way into virtually every ﬁelds of biomedical research. In this chapter we
review the technical background of the different commercially available NGS platforms with respect to template
generation and the sequencing reaction and take a small step towards what the upcoming NGS technologies will
bring. We close with an overview of different implementations of NGS into biomedical research. This article is
part of a Special Issue entitled: From Genome to Function.nome to Function.
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The growing power and reducing cost sparked an enormous range of
applications of Next generation sequencing (NGS) technology. Gradual-
ly, sequencing is starting to become the standard technology to apply,
certainly at the ﬁrst step where the main question is “what's all
involved”, “what's the basis”. It should be realized that for many appli-
cations sequencing would always have been the method of choice, yet
it was science-ﬁction, technically unthinkable and later possible but
far too costly. We perform genome-wide association studies (GWAS)
using SNP-arrays simply because we cannot afford to perform whole-
genome sequencing in ten-thousands of individuals. This is changing
rapidly and sequencing will become our molecular microscope, the
tool to get a ﬁrst look. Although replication, transcription, translation,
methylation and nuclear DNA folding are completely different process-
es, they can all be studied using sequencing.
An important advantage of sequence data is its quality, robustness
and low noise. It should be noted that a successful NGS project requires
expertise both at the wet lab as well as the bioinformatics side in order
towarrant high quality data and data interpretation. The sequence itself
is hard evidence of its correctness. A sequencing system will not pro-
duce “random” sequences and when it does this becomes evident im-
mediately from QC calls obtained from spike-in controls. Furthermore
random sequences will have no match and can be easily discardedduringdata analysis andwhen their number exceeds a certain threshold
it is evident that there is a serious problem somewhere in the study.
2. Sequence library preparation
All currently available sequencing platforms require some level of
DNA pre-processing into a library suitable for sequencing. In general,
these steps involve shearing of high molecular weight DNA into an ap-
propriate platform-speciﬁc size range, followed by an end polishing
step to generate blunt endedDNA fragments. Speciﬁc adapters are ligat-
ed to these fragments by either A/T overhang or direct blunt ligation.
A functional library requires having speciﬁc adapter sequences to be
added to the 3′ and 5′ ends. Each of the sequenceplatforms uses a differ-
ent set of unique adapter sequences to be compatible with the further
steps of the process (Fig. 1).
Following adapter ligation Life Technologies (Solid, PGM, Proton)
libraries require a nick translation step to get functional molecules
while for the other technologies the sample is in principle ready for
loading immediately after ligation. One may then choose to sequence
these libraries directly as ampliﬁcation free libraries or introduce a
pre-ampliﬁcation step prior to sequencing. It is important to realize
that any step during pre-processing which involves ampliﬁcation of
the molecules [1] or which has been shown to be sequence biased,
like ligations [2], will impose a selection on molecules that end up in
the sequenceable libraries.
3. Current sequencing technology
The different sequence platform vendors have devised different
strategies to prepare the sequence libraries into suitable templates as
Fig. 1. Structure of sequence librarymolecules for the different technologies. Linear library
molecules (Panel A) contain different adapter sequences at the 5′ [A] and 3′ [B] ends of the
library inserts. Circular library molecules (Panel B) contain identical adapter molecules at
both ends of the insert.
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the Illumina, Solid, PGM and 454 systems a local clonal ampliﬁcation
of the initial templatemolecules into polonies [3] is required to increase
the signal-to-noise ratio because the systems are not sensitive enough
to detect the extension of one base at the individual DNA templatemol-
ecule level. On the other hand, the Heliscope and PacBio SMRT systems
do not need any pre-ampliﬁcation steps as these systems are sensitive
enough to detect individual single molecule template extensions.
The different strategies to generate the sequence reads also lead to dif-
ferences in the output capacity for the different platforms (Table 1).
Below we will focus on the newer sequencing platforms, being the
Illumina, LifeTechnologies Semiconductor sequencing and PacBio.
Other older platforms will brieﬂy be discussed in Online Supplement 1.3.1. Illumina technology
All of the enzymatic processes and imaging steps of the Illumina tech-
nology take place in a ﬂow cell. Depending on the speciﬁc Illumina
platform it may be partitioned into 1 (miSeq), 2 (HiSeq2500) or 8
(HiSeq2000, HiSeq2500) separate lanes. The Illumina platform uses
bridge ampliﬁcation for polony generation and a sequencing by synthesis
(SBS) approach (Fig. 2A). Forward and reverse oligos for ampliﬁcation
(one with a cleavable site), complementary to the adapter sequences in-
troduced during the library preparation steps, are attached to the entire
inside surface of the ﬂow cell lanes. The ﬁrst step for loading the library
onto the ﬂow-cell is denaturation of the dsDNA fragments into individual
ssDNAmolecules.When on the ﬂow-cell, these hybridize to the oligo nu-
cleotides on the surface (Fig. 1A; step 1) which are used as primers to
form an initial copy of the individual sequencing template molecule
(Fig. 1A; step 2). The initial librarymolecules are removed and the copied,
ﬂow cell-attached fragments are used to generate a cluster of identical
template molecules using isothermal ampliﬁcation. This is done through
cyclic alternations of three speciﬁc buffers thatmediate the denaturation,
annealing and extension steps at 60 °C. During these steps the 3′ end of
the copied library molecules can hybridize to the complementary oligos
on the ﬂow cell, thus forming a bridge structure (Fig. 1A; steps 3–5).The ﬁnal step is to remove one strand of the dsDNA fragments
using the cleavable site in the surface oligo (Fig. 1A; step 6) and to
block all 3′ ends with ddNTP to prevent the otherwise open 3′ ends to
act as sequencing primer sites on adjacent library molecules [4].
With optimal loading of library molecules one ﬂow-cell lane will
yield approximately 800–1000 K clusters per mm2. Optimal amounts
depend not only on the concentration of the library, but also on the
length of the molecules. Short molecules yield clusters with a small
area that are denser and therefore generate more intense signals.
Loading a wide fragment size distributionwill generate clusters varying
widely in size and signal strength which may impair the number of
passing ﬁlter reads.
Bridge ampliﬁcation is not a very efﬁcient method for clonal ampli-
ﬁcation, i.e., the 35 cycles of isothermal ampliﬁcation yield a mere
~1000 copies of the initial molecule. Moreover, there will be predomi-
nantly outward growth of the clusters, there is a high probability of
the template strands to re-hybridize insteadof annealing to a newprim-
er site on the glass surface and there is both an upper and a lower limit
to the length of the templatemolecules that can be reliably ampliﬁed. In
addition, DNA polymerases, which are known to have biases towards
speciﬁc DNA templates are used during the ampliﬁcation processes.
The bridge ampliﬁcation scheme that Illumina exploits yields a high
number of clusters, i.e., with good loading of theﬂow cell, the total num-
ber of reads generated per Hiseq2000 lane may reach ~180 million.
With a paired-end 2 × 100 bp read format the total output of one
ﬂow-cell lane is up to ~36 Gb. A full run of 2 ﬂow cells sequencing in
parallel may yield ~600 Gb of data.
During sequencing, the polonies on the ﬂow cell are read one nucle-
otide at a time in repetitive cycles. During these cycles, ﬂuorescently la-
beled dNTPs are incorporated into the growing DNA chain. Each of the
four dNTP species (A, C, T, G) has a single different ﬂuorescent label
which serves to identify the base and act as a reversible terminator
to prevent multiple extension events. After imaging the ﬂuorescent
group is cleaved off, the reversible terminator is de-activated and the
template strands are ready for the next incorporation cycle. The se-
quence is read by following the ﬂuorescent signal per extension step
for each cluster. Under ideal circumstances, all bases within a cluster
will be extended in phase. However, a small portion of the molecules
do not extend properly and fall either behind (phasing) or advance a
base (pre-phasing). Over many cycles, these errors will accumulate
and decrease the signal to noise ratio per cluster, causing a decrease in
quality towards the ends of the reads.
The cycle time for the HiSeq2000 is approximately 1 h. The major
contributor is the imaging of the ﬂow-cell. The enzymatic reactions
take very little time at all. By reducing the imaging time, the whole
sequencing process can be sped up considerably. This is implemented
in the miSeq and Hiseq2500 platforms by providing the option to
decrease the total surface area to be imaged. In rapid mode, cycle time
can thereby be reduced to 5 and 10 min for the miSeq and Hiseq
2500, respectively. Furthermore, with optimized reagent kits for these
short cycle times it is possible to achieve a 2×300 bp paired end run
on the miSeq, with 85% of data points above Q30 and run times of
~65 h. However, the increased sequencing speed does come at a price.
With the decreased surface area, the total number of data points that
can be generated per run will reduce, increasing sequencing cost per
nucleotide signiﬁcantly.
Early 2014, Illumina has announced the release of two new sequencer
models, i.e., theNextSeq 500 and theHiSeqXTen. The former systemwas
designed to be a highlyﬂexible, smaller version of theHiSeq2500, provid-
ing both medium (40 Gb) and a high output (120 Gb) modes both with
run times under 30 h. The HiSeq X Ten was designed for one main
purpose: enabling whole human genome sequencing and reaching the
$1000 genome in run costs. The main advancement enabling this is the
introduction of the patterned ﬂowcells. In contrast to the spatial random
cluster generation of the HiSeq and MiSeq ﬂowcells, the X Ten ﬂowcells
contain a pre-formatted grid of nano-wells, which each can produce
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combinationwith faster scanning protocols, speciﬁcally tailored software
and new sequencing chemistry this system can produce ~600 Gb of data
in a single day or ~1.8 terabases within three days, which is enough for 5
and 15 whole human genomes, respectively.
3.2. Ion torrent technology
For the PGM/Proton sequence platforms the sequence templates
are generated on a bead or sphere via emulsion PCR (emPCR) [5,6]. An
oil–water emulsion is created to partition small reaction vesicles that
each ideally contains one sphere, one library molecule and all the re-
agents needed for ampliﬁcation. Two primers that are complementary
to the sequence library adapters are present, but one is only present
in solution while the other is bound to the sphere. This serves to select
for the library molecules with both an A and a B adapter while excluding
thosemolecules with two A or B adapters from loading on the beads dur-
ing emPCR (Fig. 2B). In addition, this ensures a uniform orientation of the
sequence library molecules on the sphere. During the emPCR steps, indi-
vidual library molecules get ampliﬁed to millions of identical copies that
are bound to the beads to allow ultimate detection of the signal.
Although one emPCR reaction can generate billions of templated
spheres, some aspects inherent to the emPCR method, in addition to
the general biases during PCR ampliﬁcation, prevent optimal output.
Due to the double Poisson distribution behavior, it is impossible to
achieve optimal loading of one library molecule into all individual vesi-
cles. In fact 1/3 of the vesicles will have the one molecule to one vesicle
ratio, the remaining 2/3 will be either without a molecule or have more
than one. In addition, breaking of the emulsion and recovery of the
spheres are inefﬁcient even with the latest automated systems. In the
ﬁnal step spheres containing ampliﬁed DNA are selected in an enrich-
ment step from empty spheres and the loaded spheres are deposited
into the sequencing chip.
The Ion torrent chip consists of a ﬂow compartment and solid state
pH sensor micro-arrayed wells that are manufactured using processes
built on standard CMOS technology. The detection of the incorporated
bases during sequencing is not based on imaging of ﬂuorescent signals
but on the release of an H+ during extension of each nucleotide. The
release of H+ is detected as a change in the pH within the sensor
wells. Due to the lack of the time consuming imaging a sequencing
run can be completedwithin 4 h. Since there is no detectable difference
for H+ released from an A, C, G or T bases, the individual dNTPs are
applied in multiple cycles of consecutive order. If upon delivery of a
dNTP no change in pH is detected in a speciﬁc well, that nucleotide is
not present in the template at the next available position. Alternatively,
if a change in pH is detected, that base is in the template. In contrast to
the Illumina's SBSmethod the dNTPs used are not blocked andwhen the
template contains a series of a nucleotide after each other (a homo-
polymer stretch), the entire stretch of identical bases will be extended,
leading to an accordingly stronger pH change which is directly propor-
tional to the number of identical bases incorporated. Relative to a single
‘A’ a stretch of ‘AA’ will give a 2 fold increase in the pH, while an ‘AAA’
template will yield a 1.5 fold (3/2) increase in pH relative to ‘AA’ and
for 6 vs. 5 identical bases this relative increase is just 1.2 fold. This
decrease of the relative increase of the change in pH as the homopoly-
mer length increases reduces the probability by which a homopolymer
region is called correctly.
The dNTPs are added in a predeﬁned ﬂow order. At the ﬁrst release
of the system, this order was a repetitive T–A–C–G sequence. As with
Illumina sequencing, not all of the template molecules on a templated
sphere get extended in perfect synchrony. On average 0.5–1% of the
molecules deviate from the ﬂow either because they lag behind due to
improper extension or they advance ahead due to carry over of dNTPs
from a previous cycle. In order to minimize this de-phasing, the ﬂow
order was changed to a more sophisticated sequence that incorporated
A–T–A catch-up type ﬂows. This scheme allows incomplete extension of
Fig. 2. Template generation via bridge ampliﬁcation (A) or emPCR (B).
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cost of decreased overall read length, the overall quality of the read does
improve. Still, the quality of the reads gradually decreases towards the
ends of the reads. By taking into account the ﬂow order, it is possible to
make ﬂow-aware base caller algorithms and ﬂow-space aware aligner
software and variant detection tools that take the actual ﬂow order into
account when processing the data in order to generate higher accuracy
data [7,8]. The present error rate for substitutions is ~0.1% [8] which is
very similar to that of the Illumina systems. The main point of criticism
the system endures is the homo-polymer errors. Despite many improve-
ments the 5-mer homo-polymer error rate is still at 3.5% [8].
Since the initial release of the Ion torrent platform, this technology has
evolved at a very rapid pace. The output specs of the ﬁrst Ion-314 chip
were a mere 10 Mb. Through increasing the total surface area of the
chips and the sensor well density, all on the 350 nm CMOS technology,
in addition to increasing the average read length from 100 up to 400 bp,
the newest Ion-318 chips produce ~1 Gb. For the Ion Proton System
110 nm CMOS technology was used to manufacture the Proton-I chips.
The diameter of the spheres and the sensor wells decreased which
allowed the number of wells to increase to ~165 million per chip. The
Proton-I chips currently yield 60–80 million reads per run, reaching
10 Gb. This is enough to sequence two human exomes at ~50× coverage.
The announced Proton-II chip will have 4× the number of sensor wells,
with an expected output of ~32 Gb per chip promising to generate a
whole human genome at ~10× coverage, still within the 4 h run time.
This output puts it at par with a paired-end run on single HiSeq2000 lane.
Life Technologies have developed an alternative method to generate
polonies called Wildﬁre [9]. The process generates clusters on a solid
surface using isothermal ampliﬁcationwithout denaturation or ampliﬁ-
cation cycles. Although initially designed for the Solid 5500 system, it
is likely that this method could be applied to the Ion torrent semicon-
ductor sequencing as well. This may involve spheres as an intermediate
carrier or clusters may be generated directly into the sensor wells.
A Proton-III chip has been announced that will double the number of
wells to 1.2 billion, leading to an expected output of ~64 Gb per run.
With these output levels, the Ion Proton will become a competitor to
the current Illumina HiSeq systems.
3.3. Paciﬁc biosciences technology
The principles underlying the paciﬁc biosciences single molecule
real-time (SMRT) sequencing technology are quite different fromthose of the above mentioned sequencers. First of all, the technology
works with single molecule detection, i.e., the optics used are sensitive
enough to detect incorporation of one ﬂuorescently labeled nucleotide.
Consequently, template preparation does not require any ampliﬁcation
steps, and the prepared library molecule is the sequencing template. Li-
brary preparation is similar to shotgun libraries for the other platforms,
i.e., fragmentation of the gDNA to the required size, here multi-kb size,
followed by end repair and either A/T overhang or direct blunt adapter
ligation. The main difference is that the adapters have a hairpin struc-
ture (SMRT loop adapters) so that after ligation the dsDNA fragments
will have become circular (Fig. 1B). Pre-preparation of the sequencing
template consists of annealing a sequencing primer to the ssDNA region
of the SMRT loop adapters, followed by binding of the DNA polymerase
to form the active polymerization complex. A combination of insert size
and read lengthwill determinewhether a shortmolecule is read several
times (CCS or consensus circular sequencing) or a long molecule only
once.
The standard PacBio DNA library preparation starting amounts can
be as high as 1–5 μg total genomic DNA or 0.5–1.0 μg sheared and size
selected DNA fragments for 10 kb libraries. These numbers are unex-
pectedly high for a system that reads single DNA molecules. These
high input requirements may limit the use of the PacBio system for
low input applications such as ChIP-Seq or single-cell genomics. The
bottleneck lies at the stringent XP bead clean-up steps and Exo III and
VII treatments during library preparation to exclude short and/or
non-circular fragments from the ﬁnal library pool. A lot of sample is lost
during these steps, but not taking these measures which would lead to
suboptimal output of the runs. Alternative methods have been explored
that bypass these stringent library preparation steps and immediately
proceed to sequencing the unprocessed DNA template molecules either
by speciﬁcally primed or random hexamer primed sequencing on plas-
mid DNA. Although the output of the SMRT cells was far below standard
specs, Coupland et al. were able to sequence the entire M13mp18 ge-
nome at average 56× coverage using as little as 3.1 ng input DNA [10].
These experiments demonstrated that it is possible to directly sequence
small single- and double-stranded DNA genomes without the need for
any DNA hungry library preparation steps.
The sequencing reaction takes place at the bottom of the ~150,000
zero-mode waveguide (ZMW) wells [11] on a SMRT cell. These ZMW
are small reactionwells that each ideally contains one complex consisting
of template molecule, sequencing primer and DNA polymerase bound to
the bottom of the ZMW [12]. Unlike the Illumina and Life Technologies
1936 H.P.J. Buermans, J.T. den Dunnen / Biochimica et Biophysica Acta 1842 (2014) 1932–1941platforms, PacBio does not rely on interrupted cycles of extension and im-
aging to read the template strand. Instead, the ﬂuorescent signals of the
extended nucleotides are recorded in real time at 75 frames per second
for the individual ZMWs. This is achieved by a powerful optical system
that illuminates the individual ZMWs with red and green laser beamlets
from the bottomof the SMRT cell and a parallel confocal recording system
to detect the signal from the ﬂuorescent nucleotides [13]. The width of
the ZMWs is chosen in relation to the laser wavelength such that the
light cannot pass through the ZMWs but a zeptoliter sized illumination
zone is formed at the bottom of the ZMWs where the active polymerase
complex is bound.
Aswith the Illuminaplatform, the four nucleotide species are labeled
with a different ﬂuorescent label. However, a crucial difference is that
the label for the PacBio system is terminally phospholinked nucleotides,
meaning the label is cleaved off during strand extension. In addition, the
nucleotides do not contain a terminator group allowing continuous
extension of the growingDNA copy.When a nucleotide complementary
to the template is bound in position by the polymerase within the illu-
mination zone of the ZMW, the identity of the nucleotide is recorded
by its ﬂuorescent label. During extension the label is cleaved off, diffuses
outside the illumination zone, and the complex is ready for the next
extension. In essence, the system records a movie of the activity of the
polymerase during a rolling circle ampliﬁcation of the template. The po-
lymerase used for sequencing in the PacBio system is amodiﬁed version
of phi29 [14]which although exhibiting reduced 3–5 exonuclease activ-
ity, still has many of the properties of the original phi29 like high
processivity of several hundred kilobases, low error rate of ~10e−5
[15], no GC bias and strand displacement properties [16].
Through several advancements at the technological, bioinformatics
and chemistry level, the average output per SMRT cell has increased
considerably since the release of the system early 2011. The output
has mainly increased though achieving longer average read lengths,
starting from the ~1 kb at the time of release, while the number of
reads passing ﬁlter remained ~50–60 K per SMRT cell. Although the
maximal achievable read lengths that can be obtainedwith this technol-
ogy are directly related to the length of the sequencing time, not all
polymerase complexes reach identical read lengths. The main cause
for this is photo-damage of the phi29 polymerase which terminatesFig. 3. Total read length distribution for PacBio reads obtained with the P5 enzyme in combina
black line (right y-axis) represents the total amount of data from reads longer than the read
The total number of bases and reads is indicated with the average per SMRT cell in parenthesethe sequencing reaction. In the C3 chemistry, photo-protected nucleo-
tide analogs are used which shield the polymerase from damage and
consequently, half of the reads are over 8–10 kb in length when
using the P5 enzyme (Fig. 3). With the current max. movie length of
180 min, read lengths of over 40,000 bases have been reported. With
these speciﬁcations the output per SMRT cell reaches ~400 Mb for the
PacBio RSII.
One much debated aspect of the PacBio data is the high single pass
error rate of 10–15%, themajority of which are insertion/deletion errors
with only a small fraction of miscalls. It is important to keep in mind
that in contrast to the other sequencing technologies, the errors in the
PacBio reads are randomly distributed anddonot occurmore frequently
towards the end of the reads. This property can be used to create con-
sensus calls from information of multiple reads covering each reference
position. Consensus accuracy can reach over 99.999% by using the
PacBio Quiver software [17]. Although this does require a coverage of
~40× per base, these levels can easily be reached with the output of a
few SMRT cells for small (bacterial) genomes.
Despite the relatively low output of the system per SMRT cell, the
PacBio long read data, absence of GC bias and insight into the kinetic
state of the polymerase during sequencing present a niche of speciﬁc
applications for this system that cannot be covered by any of the other
currently available sequence platforms.
4. Future sequencing technology
The advancements made on sequencing technology over the last
years have been impressive. However, the ultimate sequencing plat-
form would work on single DNA or RNA molecules without any (pre-)
ampliﬁcation, without use of optical steps, reads of Mb to Gb in length,
noGC bias, high read accuracy andwould be ﬂexible enough to generate
as many sequence reads as are necessary for the speciﬁc research ques-
tion at hand. In addition, it should be both cheap to acquire and run,
easy to operate, have short run times and simple or no library pre-
preparation steps. Needless to say, this sequencing platform does not
exist, yet. In the next section we will discuss one emerging sequencing
platform which may have the potential to make the next step towards
these ultimate sequencers.tion with the C3 chemistry. Blue bars (left y-axis) represent the number of reads and the
length on the x-axis. The data presented is from 8 SMRT cells run on the same library.
s.
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Expected characteristics for the nanopore sequencers are single
molecule, ampliﬁcation free, base detection without labels, long reads,
low GC bias and scalable in data output. The basic principle behind the
technology is tunneling of (polymer)molecules through a pore that sep-
arates two compartments. Physical presence of the molecule passing
through the pore causes a characteristic temporary change in the poten-
tial between the two compartments which allows for identiﬁcation
of the speciﬁc molecule [18]. Two version of nanopore DNA sequencing
are being developed, i.e., using the natural pore forming protein alpha-
hemolysin [19] or manufactured solid state pores [20,21].
Oxford nanopore technologies (ONT) is one of the companies work-
ing on building nano-pore sequencing devices. Although ONT has put
their focus on nucleic acid sequencing, in principle this technology
could be applied to any (bio-)polymer as long as the molecules yield
distinguishable changes in the current between the compartments. In
Q4 2012 Oxford nanopore announced the early access release of their
MinION system. This is a palm sized sequencing device that facilitates
real-time analysis of single molecules such as DNA and RNA. However,
speciﬁcs on read length, accuracy and run times are difﬁcult to obtain.
5. NGS applications
Below we will brieﬂy describe a range of NGS applications. Each
application requires a minimal amount of reads of a pre-deﬁned length
in order to obtain a datasetwhich allows the researcher to draw reliable
conclusions. Speciﬁcations differ for each application but in Table 2
we give a rough indication of the minimal dataset required. Still, de-
pending on the speciﬁc research question, the number of reads and/or
read length may differ.
5.1. Expression analysis
The development of micro-array technology revolutionized bio-
medical research, for the ﬁrst time allowing overall characterization
(genome-wide) of gene expression. Yet the technology had several
ﬂaws limiting sensitivity and speciﬁcity, that are overcome by sequenc-
ing. A ﬁrst application of NGS was in gene expression proﬁling. While
detection of low expressed genes usingmicro-arrays is limited by back-
ground noise, sensitivity of sequence based studies is predominantly
limited by the depth of sequencing. Recent publications show that
RNA-based gene expression can be measured in many ways. Initially,
cost-directed, SAGE-like approaches were popular [22], but dropping
costs now drives analysis towards full RNA sequencing (RNAseq) [23],
requiring much deeper sequencing yet through analysis of the entire
transcript revealing the complete picture incl. differential splicing and
allelic expression. A combination of SNP-array based GWAS studies
and NGS-based RNAseq is now used to study gene activity per allele
and detect variants that affect transcription both in cis and trans
(eQTLs) [24]. NGS has also been extensively used to study RNA structure
in detail and speciﬁc methods were developed to characterize e.g. tran-
scription initiation using the 5′-start (cap site) [25] or the 3′-end of tran-
scripts [26].
Small RNAs were re-discovered and large studies were performed
measuring e.g. miRNA expression in great detail [27,28]. Enhancers
were recently found to initiate RNApolymerase II transcription, produc-
ing so-called eRNAs. Through the presence of balanced bidirectional
capped transcripts (from CAGE analysis), the FANTOM5 consortium
was able to obtain a genome-wide atlas of active enhancers across
human cell types and tissues [29].
A recent addition is ribosome proﬁling [30] where not all RNA is
isolated but only that RNA which at the time of sampling is being trans-
lated into protein. Besides giving a picture much closer to protein levels
the technology can also be used to annotate the genome (translation ini-
tiation site, termination site and reading frame used). Finally transcriptsreveal whether they contain the so-called untranslated open reading
frames (uORF), in yeast often found in stress-related genes.
5.2. ChIP-seq
Another application boosted by NGS technology was the study of
protein binding sites in genomic DNA, especially that of transcription
factor binding sites based on Chromatin ImmunoPrecipitation (ChIP)
[31]. Initially ChIP-enriched sequences were analyzed using array
technologybut since array contentwas limited choices had to bemade re-
garding the sequences to analyze. In general promoter regions of genes
and CpG-rich regions were selected. Since it was often difﬁcult to enrich
the sequences of interest to high purity, the signals obtained were often
rather weak. The advantage of sequencing the ChIP-products enriched is
that all sequences bound are identiﬁed and that the number of sequence
read can be used to determine the sensitivity; even when enrichment is
weak, increasing the number of reads can help to obtain a good signal.
Many studies have been performed using ChIP-seq and DNase I hyper-
sensitive site (DHS) mapping of which those of the ENCODE [32] and
FANTOM5 [29] projects are most impressive, revealing genome wide
proﬁles and binding sites for a range of DNA binding proteins.
5.3. Methylation
Like ChIP-seq, the power ofNGS gave a boost to the study of (genome-
wide) DNAmethylation. Irrespective of the technology used to isolate the
methylated sequences, e.g., methylated DNA immunoprecipitation-
sequencing (MeDIPseq), methylated CpG island recovery assay (MIRA-
Seq) or whole-genome shotgun bisulphite sequencing (WGSBS)
(reviewed in Liard et al [33]), NGS-analysis clearly reveals all sequences
enriched. Besides enriching methylated DNA sequences, chemical tricks
can be used to identifymethylated nucleotides. Sequencing both untreat-
ed and bisulphite-treated DNA will highlight the C-nucleotides that
are methylated and not chemically converted resulting in a T when se-
quenced. Although powerful, the lower complexity of the bisulphite
treatedDNA (most C's converted to a T)will cause some problems during
analysis (determining the origin of the reads obtained). Another compli-
cating factor is that, since methylation is usually not 100%, a signiﬁcant
sequence depth will be required to get meaningful results. Single
molecule sequencing technologies, like that of paciﬁc biosciences
(see above), are attractive alternatives especially since they are able to
detect all DNA modiﬁcations present and not only methylation of
C-residues. Many NGS methylation studies have been presented
amongwhich those of the ENCODE consortium [32]. An elegant smaller
study is that byHerb et al. [34] in honeybees where they show that sub-
stantial differences exist in the methylation pattern in the brain be-
tween nurses and foragers but not between a queen and the worker
castes. Interestingly, the difference between nurses and foragers was
reversible.
5.4. De novo genome sequencing
A main application of NGS technology is the complete characteriza-
tion of the entire genome of a particular species. After tackling ﬁrst the
main model organisms (yeast, Escherichia coli, Drosophila, Arabidopsis,
mouse) and the human genome, an ever increasing number of genome
sequences is currently being performed. An important player here is BGI
(Beijing Genomics Institute) with statements like “Does it taste good,
we'll sequence it”, “Does it look cute, we'll sequence it” and their
“1000 Plant and Animal Reference Genomes Project” and Ten Thousand
Microbial Genomes Project. Considerable effort has also been invested
in the analysis of genomes from endangered or even extinct species,
like the panda [35], mammoth [36] and early humans [37]. Together
these projects produce an enormous amount of data that, besides for
some evolutionary studies, remains largely unstudied.
Table 2
Recommendation for data requirements for a selection of NGS applications.
Application # reads/sample Run type # read length (bp) Remark
Transcriptome analysis
Tag based (SAGE/CAGE) N10 million Single end 20–50
SmallRNA N10 million Single end 20–50
mRNA Seq N30 million Paired-end N50 Efﬁcient exclusion of rRNAderived sequences increases
the resolution of the transcripts of interest
Ribosome proﬁling N20 million Single end 20–50
ChIP-Seq N20 million Single or Paired-end ≥50 Speciﬁcity of the ChIP enzyme determines the # reads
needed. Low speciﬁcity ~ more background = more
reads needed
De novo sequencing 30× genome coverage,
preferably more.
long single-end reads and Paired-end As long as possible Ideal PacBio long reads. Or combination of paired-end,
mate-pair and PacBio.
Meta-genomics
Tag based (ITS, 16S) N100,000 Paired-end, long single-end reads As long as possible Complexity of the speciﬁc biosphere determines both
the primer pairs and/or #reads per sample. Longer
reads allow for better differentiation between related
species
Shotgun N100 million Paired-end, long single reads As long as possible Complexity of the speciﬁc biosphere determines the
library insert size and/or #reads per sample.
Methylation analysis
Whole genome N400 million Paired-end ≥100 Ideal situation: all PacBio long reads on native/
unmodiﬁed shotgun libraries.
Enrichment strategies N50 million Paired-end ≥100
Infections N25 million Single or Paired-end ≥100 ~2% of cell-free DNA from plasma is of non-human
origin
Non-invasive prenatal testing N10–20 million Single-end N50 Trisomy detection from cell-free fetal DNA in maternal
plasma
Disease gene identiﬁcation diagnostics
Whole genome 1 billion Paired-end ≥100 30× average coverage
Exome (50 Mb) N60 million Paired-end ≥100 50× average coverage, N75% on target
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A complex variant of de novo genome sequencing is “sequence it
all”, metagenomics. Using brute force sequencing, simply reading all
DNA sequences present in a sample, metagenomics is a way to make
an inventory of what is present in a sample, of what is living where. A
simple but effective application of this is trying to detect the cause of
an infectious disease. Simply analyzing all DNA from control versus
infected (diseased) individuals will reveal the “extra” DNA which most
likely derives from the infectious agent. The approach was used success-
fully to identify e.g. colony collapse disorder killing honeybees [38] but
also to identify the cause of diseases that killed thousands of humans in
the past, inclusive the black death [39].
Metagenomics can be performed by a sequence it all approach or by
focusing on speciﬁc uniformly conserved sequences like e.g. ribosomal
RNA genes only. The latter approach has two main advantages; 1) the
complexity of the data obtained ismuch smaller, and 2)more sequences
can be assigned to a speciﬁc organism or a group of related organisms.
The latter facilitates some semi-quantitative analysis which is much
more difﬁcult when analyzing all sequences mixed from many organ-
isms with largely varying genomesizes. Metagenomics focussing on
rDNA genes has been used to study many different things, incl. e.g. the
effect of the 2004 tsunami on microbial ecologies in marine, brackish,
freshwater and terrestrial communities in Thailand [40]. Targeting the
chloroplast trnL gene was successfully used to study airborne pollen
and its relation with hay-fever [41].
A unique feature of metagenomics approaches is that one does not
need to culture the organisms that one wants to study. The most im-
pressive result of ﬁrst studies that read all DNA sequences was that up
to ten times more organisms were encountered than seen previously.
One can now study organisms that no one is able to culture and/or
that no one has ever seen. Based on DNA sequencing one gets an idea
of the complexity and constitution of entire ecosystems [42,43]. UsingRNA sequencing one gets an overview of “what's happening” [44].
The technology facilitates the study of the consequences of environ-
mental changes as well as way to determine the cause of disturbances.
Enormous progress has been made in a medical setting. Studying the
human microbiome gave a range of surprising ﬁndings, incl. its enor-
mous complexity containing 10× more cells than the human body
and 1000× more genes. The microbiome of the human gut has been
studied in great detail [45] including its relation with phenotypes like
obesity [46]. Microbiomics is hot and it will undoubtedly bring new
insights in the interplay between human health and the bugs living on
and in within us.5.6. Non-invasive prenatal testing
To obtainDNA froma fetus, prenatal diagnosis generally involves the
costly and risky sampling of either chorionic villi or amniotic ﬂuid. It is
long known that DNA of the fetus can be found in maternal blood (cell
free serum), yet it has low abundance and low quality and it is not
easy to discriminate fetal from maternal DNA. These characteristics
prevented wide-spread implementation of prenatal tests performed
on maternal blood. However, the enormous power of NGS technology
seems particularly attractive for non-invasive prenatal testing (NIPT).
To detect trisomies, in particular trisomy-21 or Down's syndrome, a
very simple but effective brute-forcemethodwas developed: sequence,
map, and count. DNA isolated frommaternal serum is sequenced, reads
are mapped to the human genome and counted per chromosome.
When 5–10 million reads are mapped, trisomies will reveal themselves
by giving a signiﬁcantly too high number of reads mapping to a partic-
ular chromosome [47]. A recent study showed that when genome se-
quencing of both parents, genome-wide maternal haplotyping and
deep sequencing of maternal plasma DNA are combined even the ge-
nome sequence of an 18.5 weeks human fetus can be determined [48].
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A combination of genome-wide association studies (GWAS) and
speciﬁc targeting by sequence capture of the genomic regions detected
is now used extensively trying to identify the variants that functionally
link the DNAwith the phenotype. Similarly, genome sequencing can be
used as a tool to characterize genetic variation in a speciﬁc population,
determine haplotype structure and use this knowledge to impute alleles
and boost the outcome of GWAS analysis [GoNL consortium, 2014, in
press].
One of the most impressive applications of NGS lies in the ﬁeld of
human genetics and disease gene identiﬁcation. In the past larger fam-
ilies were an absolute requirement for a successful approach. Without
being able to ﬁrst map a disease gene to a speciﬁc position and then
zooming in on the genes in that region, the human genome was simply
too big and analysis too costly. Some successes were obtained using
candidate disease gene approaches but generally these only worked
when for a speciﬁc disease a new gene was discovered making similar
genes or neighboring genes in a certain pathway obvious candidates.
NGS studies were much more successful, even when only one or a few
cases are available [49]. Parent–child trio analysis turned out to be
very effective to reveal dominant de novo diseases [50], while recessive
diseases can be revealed when several unrelated cases are available or
when clearly damaging variants are present [51]. The latter successes
could already be obtained with exome sequencing, i.e. a method to
zoom in on the 1–2% protein coding sequences of the human genome
only. Needless to say that, when cost drops further, full genome
sequencing will be used to detect also deleterious variants that are not
in the protein coding regions. Early steps towards the ultimate applica-
tion, genome-based medicine/personalized medicine have been set
by the UK and Saudi Arabia which last year both announced projects
to sequence the genome of 100,000 individuals.
5.8. Human disease and health
Thus far studies have been mostly performed on the level of cell
cultures, whole tissues or sorted cell populations. Although the yield
per cell, 30%–70% of all RNA or DNA present, can still be improved, re-
cent NGS developments have nowmade genome-wide single cell anal-
ysis feasible. Individual cells turn out to be quite different showing
extensive genomic and transcriptomic heterogeneity in both normal
development and disease [52]. This turns out to be especially true
for cancer tissue being a complexmixture ofmany different cell popula-
tions each carrying a range of genomic rearrangements driving its unre-
stricted growth. Dissecting these using (very) deep sequencing of the
cancer genome/transcriptome as a whole or from single cell analysis
should give us a tool to identify the so-called driver mutations. These
will be different in different tumors and instrumental to direct treat-
ment and prescribe the best (set of) drugs to be used, personalized
cancer treatment. Similarly NGS approaches will be used to study drug
resistance, identify their mechanism and provide strategies to combat
resistance [53]. Coordinated by the International Cancer Genome
Consortium (ICGC) a large project is ongoing trying to resolve the geno-
mic changes present in many forms of cancers by analyzing 50 cancer/
normal tissue pairs [54]. In due time NGS developments will start to
impact our daily life.While it will initially be used as amolecularmicro-
scope to diagnose disease, ultimately it will also be used to monitor our
personal health. Our genome sequencewill be read once, but e.g. blood-
derived RNA analysis, completed with proteomics and metabolomics
measurements, will be used on a regular basis to study the status of
our body [55], the Whole-body-BIOscan.
5.9. Single molecule & long read sequencing
It should be noted that high accuracy sequences, i.e. sequences con-
taining few read errors, are not essential for all applications. For speciﬁcstudies, low accuracy (N85%) single-molecule long-read sequences can
be sufﬁcient tomake a signiﬁcant difference. De novo genome assembly
can be improved considerablywhen long kilobase-sized reads are avail-
able that span gaps from short-read paired-end sequencing. The single-
molecule technologies are ampliﬁcation free and thereby not hampered
by PCR-based artifacts like uneven ampliﬁcation and GC-bias. Conse-
quently, they give a much more uniform coverage and span GC-rich
regions. In addition they may span repeat structures or duplications
that cannot be resolved using short read sequencing. English et al.
have used PacBio data for upgrading existing draft genome assemblies
derived from Illumina sequencing data by looking for reads that extend
into or cover gaps in the assembly [56]. A paper by Loomis et al. showed
that the system has no problems sequencing long regions of 100% GC
content of CGG trinucleotide repeat expansions [57].
Ampliﬁcation-free methods facilitate the analysis of DNA modiﬁca-
tions, deriving from either cellular processes like methylation [58]
and/or from damage (irradiation, chemicals, etc) [59]. DNA modiﬁca-
tions present on the template molecule affect the DNA polymerase
activity to a certain extent, i.e., the time needed for incorporation of a
nucleotide at a particular site. The identity of modiﬁcations can
be inferred by analysis of the kinetic state of the polymerase. This
works well for modiﬁcations that have a large effect on the polymerase
activity, e.g., N6-methyladenine (m6A) and N4-methylcytosine (m4C)
[60,61]. The 5-methylcytosine (m5C) modiﬁcation has a weaker signal
but given enough coverage can still be inferred from the data [61]. How-
ever, conversion of 5-methylcytosine to 5-carboxylcytosine through
the Ten-eleven Translocation Gene Protein 1 (Tet1) results in a greater
disturbance in the signal, thus making it easier to detect even at lower
coverage [62].
Other applications of long-read sequencing are RNA structure analy-
sis [63] and studies to unravel complex repeat structures (e.g. segmental
duplications in the human genome) and large segments of repetitive
DNA.
6. Online supplement
6.1. Solid sequencing
The Solid systems read DNA by an intricate sequencing-by-ligation
scheme [64]. After positioning the templated beads on the ﬂow-cell,
the ﬁrst step is hybridization of a primer complementary to the com-
plete adapter followed by hybridization of octamer probes. The ﬁrst
two nucleotides of these probes represent 16 dinucleotide combina-
tions, bases 3–5 are degenerate and bases 6–8, also degenerate, contain
a ﬂuorescent label for identiﬁcation of bases 1 and 2. Four different di-
nucleotide combinations are labeled with the same ﬂuorescent tag.
Use of 4 different ﬂuorescent groups allows for labeling all 16 dinucleo-
tide tags. When a probe anneals adjacent to the adapter primer strands
are ligated and information on the ﬁrst two bases is recorded from the
ﬂuorescent signal at bases 6–8. These last three bases are removed
and new octomer probes are allowed to hybridize and ligate, providing
information on bases 6 and 7, i.e., position +5 relative to the previous
cycle, of the template. Depending on the required read length, 5–7 of
such cycles are performed after which the entire synthesized strand is
removed from the template. A new primerwith a−1 nt shift in end po-
sition is hybridized and octomer probes are allowed to hybridize and li-
gate in 5–7 cycles as described above, but nowprobing nucleotides 0–1,
5–6, and 10–11 etc. of the template. In total 5 of these re-priming cycles
are performed. The template sequence is subsequently decoded from
the color labels from the two ligation events per base [65].
Similar to Illumina sequencing, the Solid system is able to generate
paired-end reads. However, due to limitations of sequencing by ligation
scheme themaximal read length is limited to 75 bases for read 1 and 35
bases for read 2. Although the total number of reads generated per Solid
run is comparable to HiSeq, the total output in Gb per run is only half of
that for HiSeq due to the shorter read length. Themain advantage of this
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which results in a signiﬁcant increase in read accuracy which may be
as low as 0.01%. By adding yet another re-priming cycle, the accuracy
can theoretically be improved even more.6.2. Roche 454
The Roche company has produced two Pyrosequencing [66] plat-
forms, i.e., the FLX+ and the bench top GS Junior system, on the same
technology. Similar to Ion torrent sequencing, templated beads are de-
posited in a picotiter plate to separate the individual sequence reactions
and T–A–C–G nucleotide ﬂows are applied to the plate. Themain differ-
ence is that the sequencing reaction ismonitored bydetection light gen-
erated by luciferase-mediated conversion of luciferin to oxyluciferin
upon primer extension. For a long time, the main niche for these sys-
tems was the long read lengths of 500–800 bp. However, increased
read lengths for competitor platforms have made pyrosequencing less
cost efﬁcient. The Roche systems were announced to be phased out in
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